Skip to content

Azapropazone

MUSCULO-SKELETAL SYSTEM

Also known as: AHR-3018, apazone, apazone dihydrate, azapropazone dihydrate, cinnamin, cinnopropazone, prolixan

YEAR INTRODUCED approvedATC M01AX04

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Azapropazone is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1972. DrugCentral lists 2 molecular targets, including PTGS1 and XDH. Recorded indications include Ankylosing spondylitis, Gout, Osteoarthritis and Rheumatoid arthritis.

  • Molecular targets: PTGS1 and XDH (2 listed in DrugCentral).
  • Indications: Ankylosing spondylitis, Gout, Osteoarthritis and Rheumatoid arthritis.
  • ATC code: M01AX04 (Other antiinflammatory and antirheumatic agents, non-steroids).
  • Molecular formula: C16H20N4O2; molecular weight 300.36 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (4)

  • Ankylosing spondylitis
  • Gout
  • Osteoarthritis
  • Rheumatoid arthritis

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Prostaglandin G/H synthase 1PTGS1unknown—
Xanthine dehydrogenase/oxidaseXDHunknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1972-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
M01AX04MUSCULO-SKELETAL SYSTEM › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS › Other antiinflammatory and antirheumatic agents, non-steroids

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Azapropazone is on its molecule page.

Molecular formulaC16H20N4O2
Molecular weight300.36 g/mol
CAS number13539-59-8
InChIKeyMPHPHYZQRGLTBO-UHFFFAOYSA-N
PubChem CID26098
CCCC1C(=O)N2N(C1=O)C1=CC(C)=CC=C1N=C2N(C)C

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Azapropazone used for?

DrugCentral lists the following indications for Azapropazone: Ankylosing spondylitis, Gout, Osteoarthritis and Rheumatoid arthritis.

How does Azapropazone work?

Its molecular targets in DrugCentral include PTGS1 and XDH.

When was Azapropazone first approved?

Azapropazone was first approved by the YEAR INTRODUCED in 1972.

What is the chemical formula of Azapropazone?

Azapropazone has the molecular formula C16H20N4O2 and a molecular weight of 300.36 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1972-01-01
AgencyYEAR INTRODUCED
Targets2
Indications4
FormulaC16H20N4O2
DrugCentral ID266
Interactive profile